These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 24747578)
1. Quantitative insights for the design of substrate-based SIRT1 inhibitors. Kokkonen P; Mellini P; Nyrhilä O; Rahnasto-Rilla M; Suuronen T; Kiviranta P; Huhtiniemi T; Poso A; Jarho E; Lahtela-Kakkonen M Eur J Pharm Sci; 2014 Aug; 59():12-9. PubMed ID: 24747578 [TBL] [Abstract][Full Text] [Related]
2. Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors. Kumar A; Chauhan S Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28025857 [TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results. Opera TI; Waller CL; Marshall GR Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806 [TBL] [Abstract][Full Text] [Related]
4. Molecular design of new aggrecanases-2 inhibitors. Shan ZJ; Zhai HL; Huang XY; Li LN; Zhang XY Bioorg Med Chem Lett; 2013 Oct; 23(19):5339-50. PubMed ID: 23953188 [TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods. Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818 [TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach. Puntambekar D; Giridhar R; Yadav MR Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255 [TBL] [Abstract][Full Text] [Related]
7. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T; Zhu L; Chen L; Xu X J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563 [TBL] [Abstract][Full Text] [Related]
8. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2. Huhtiniemi T; Salo HS; Suuronen T; Poso A; Salminen A; Leppänen J; Jarho E; Lahtela-Kakkonen M J Med Chem; 2011 Oct; 54(19):6456-68. PubMed ID: 21895016 [TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA). Ma X; Xiang G; Yap CW; Chui WK Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391 [TBL] [Abstract][Full Text] [Related]
11. Protein-based alignment in 3D-QSAR of FBPase inhibitors. Yi P; Di YT; Liu W; Hao XJ; Ming Y; Huang DS; Yang J; Yi ZZ; Li ZJ; Yang RD; Zhang JC Eur J Med Chem; 2011 Mar; 46(3):885-92. PubMed ID: 21269737 [TBL] [Abstract][Full Text] [Related]
12. Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors. Castilho MS; Postigo MP; de Paula CB; Montanari CA; Oliva G; Andricopulo AD Bioorg Med Chem; 2006 Jan; 14(2):516-27. PubMed ID: 16203153 [TBL] [Abstract][Full Text] [Related]
13. Integrated Ligand and Structure-Based Investigation of Structural Requirements for Silent Information Regulator 1 (SIRT1) Activation. Gupta AK; Choi S Curr Top Med Chem; 2018; 18(27):2313-2324. PubMed ID: 30569858 [TBL] [Abstract][Full Text] [Related]
14. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Akula N; Lecanu L; Greeson J; Papadopoulos V Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234 [TBL] [Abstract][Full Text] [Related]
16. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092 [TBL] [Abstract][Full Text] [Related]
17. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1). Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371 [TBL] [Abstract][Full Text] [Related]
18. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies. Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735 [TBL] [Abstract][Full Text] [Related]
19. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses. Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726 [TBL] [Abstract][Full Text] [Related]
20. Molecular docking and 3D-QSAR CoMFA studies on indole inhibitors of GIIA secreted phospholipase A(2). Mouchlis VD; Mavromoustakos TM; Kokotos G J Chem Inf Model; 2010 Sep; 50(9):1589-601. PubMed ID: 20795712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]